Guardant in the News

April 9, 2021

Discussing the Pivotal Role Biomarker Testing Plays in Treatment of Lung Cancer Patients

Worldwide, lung cancer is the leading cause of cancer death,1 and in the U.S., more than 235,000 people will be diagnosed with lung cancer this year.2 Non-small cell lung cancer (NSCLC) is a devastating disease that accounts for 84% of all lung cancer diagnoses.2

March 26, 2021

Catching cancer extremely early

Better, faster, and earlier: Cancer screening has come of age, with many methods capable of testing multiple cancers in one sample.

March 12, 2021

We Must Implement Covid Relief Because Cancer Doesn’t Wait

Two weeks ago, I was proud to join more than 150 business leaders in signing a letter urging Congress to swiftly adopt a COVID-19 stimulus and relief plan. Today, I am thrilled that the American Rescue Plan has been signed into law by President Joe Biden. This relief package is a significant and necessary step in the fight against COVID that will invigorate the public health response to the crisis and support desperately needed vaccination efforts.

February 14, 2021

Helmy Eltoukhy’s Big Idea That Might Change The World

Scaling applies to people, not just companies — one has to keep learning new skills, on and off the job, to be able to continue adding value to hyper-scaling companies. Learning to hire, manage, lead, write, present more effectively are all necessary growth curves that young founders must dedicate time towards.